Dr. Michael H. Albrink, MD

Dr. Albrink practices at Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital.

Dr. Albrink's NPI, 1720090103, was assigned on August 13, 2006. Dr. Albrink graduated from Ohio State College of Medicine in 1978. Dr. Albrink holds Florida license ME56661.

Dr. Albrink's primary practice is Tampa General Hospital, at 1 Tampa General Cir, Tampa, FL 33606 in Hillsborough County. The practice phone is (813) 844-7000.

Dr. Albrink's primary practice is Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Albrink to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Albrink practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Albrink's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Albrink is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Albrink's licenses on file in 2 states: Florida and West Virginia.

Dmand AI lists abdominal hernia repair surgery, acute gallbladder or bile duct inflammation, gallbladder removal, gastrointestinal bleeding and groin hernia surgery among the conditions Dr. Albrink treats.

CMS data shows 174 Medicare services from Dr. Albrink across 5 procedure codes in 2024, for 149 Medicare patients. Medicare paid $21,313 for them.

CMS counts 149 Medicare patients who saw Dr. Albrink in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Albrink's median patient age at 63, with 36% women.

In 2024, Dr. Albrink wrote 39 Medicare Part D claims for 20 patients. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $910 in total drug cost. In 2022, CMS named 23 claims across 2 drugs.

Dr. Albrink accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Albrink as offering telehealth. CMS counts 31 procedures of hernia repair (minimally invasive) by Dr. Albrink, more than 95% of the clinicians it reports for that procedure.

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Albrink, published from 2008 to 2015. 2012 was the busiest year, with 2. The most frequent topics are Laparoscopy, Postoperative Complications and Cholecystectomy, Laparoscopic. Dr. Albrink has published most often in Am Surg. Dr. Albrink's most frequent co-authors are Sharona B. Ross, MD, Larry C. Carey, MD and Connor Andrew Morton, MD.

Dmand AI links Dr. Albrink to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Hernia, Hiatal and Hernia, Diaphragmatic. University of South Florida sponsors the most, 4.

CMS Open Payments shows 75 general payments to Dr. Albrink from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 41% of the total. Allergan Inc. paid the most, $3,564. It also lists 1 research payment totaling $700 in 2017.

Dmand AI lists 5 awards for Dr. Albrink, most recently CMS Stage 1 EHR in 2013.

Dr. Albrink graduated from Ohio State College of Medicine in 1978. Dr. Albrink is a member of ACS and SLS.

Dr. Albrink is in network with 19 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.